ABUS vs GNRC · P/E 5.4, rev $6.2M vs P/E 82, rev $4.21B
Arbutus Biopharma Corp (ABUS) versus Generac Holdings Inc (GNRC) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Generac Holdings Inc (GNRC) is a specialty industrial machinery company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported GNRC revenue for 2025-12-31 was $4.21B. Net income was $159.6M. Revenue was down 2.0% from 2024-12-31 to 2025-12-31. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
Not investment advice. Open the ABUS and GNRC stock pages for the full models.
Not investment advice.